Black Swan Pharmaceuticals Inc.
Black Swan Pharmaceuticals Inc.
Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders.
Company Location
9008 Laura Lake Drive
Wake Forest
NC
27587
County
Region
Company Details
Company type
Year founded
2018
Employment range in NC
US headquarters
North Carolina
Global headquarters
Australia
Primary site activity
All company activities
Potential end market(s)